BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 31022050)

  • 1. Updates in the Neuoroimaging and WHO Classification of Primary CNS Gliomas: A Review of Current Terminology, Diagnosis, and Clinical Relevance From a Radiologic Prospective.
    Colip C; Oztek MA; Lo S; Yuh W; Fink J
    Top Magn Reson Imaging; 2019 Apr; 28(2):73-84. PubMed ID: 31022050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adult Glioma WHO Classification Update, Genomics, and Imaging: What the Radiologists Need to Know.
    Bai J; Varghese J; Jain R
    Top Magn Reson Imaging; 2020 Apr; 29(2):71-82. PubMed ID: 32271284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging of Central Nervous System Tumors Based on the 2016 World Health Organization Classification.
    Ly KI; Wen PY; Huang RY
    Neurol Clin; 2020 Feb; 38(1):95-113. PubMed ID: 31761063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Practical implications of integrated glioma classification according to the World Health Organization classification of tumors of the central nervous system 2016.
    Malzkorn B; Reifenberger G
    Curr Opin Oncol; 2016 Nov; 28(6):494-501. PubMed ID: 27606698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2016 World Health Organization Classification of Central Nervous System Tumors.
    Wen PY; Huse JT
    Continuum (Minneap Minn); 2017 Dec; 23(6, Neuro-oncology):1531-1547. PubMed ID: 29200109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in the molecular genetics of gliomas - implications for classification and therapy.
    Reifenberger G; Wirsching HG; Knobbe-Thomsen CB; Weller M
    Nat Rev Clin Oncol; 2017 Jul; 14(7):434-452. PubMed ID: 28031556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffuse gliomas to date and beyond 2016 WHO Classification of Tumours of the Central Nervous System.
    Onizuka H; Masui K; Komori T
    Int J Clin Oncol; 2020 Jun; 25(6):997-1003. PubMed ID: 32468200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shedding Light on the 2016 World Health Organization Classification of Tumors of the Central Nervous System in the Era of Radiomics and Radiogenomics.
    Colen RR; Hassan I; Elshafeey N; Zinn PO
    Magn Reson Imaging Clin N Am; 2016 Nov; 24(4):741-749. PubMed ID: 27742114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Applications of molecular neuro-oncology - a review of diffuse glioma integrated diagnosis and emerging molecular entities.
    Wood MD; Halfpenny AM; Moore SR
    Diagn Pathol; 2019 Apr; 14(1):29. PubMed ID: 30967140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Evolving Classification of Diffuse Gliomas: World Health Organization Updates for 2021.
    Perez A; Huse JT
    Curr Neurol Neurosci Rep; 2021 Nov; 21(12):67. PubMed ID: 34817712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WHO 2016 Classification of gliomas.
    Wesseling P; Capper D
    Neuropathol Appl Neurobiol; 2018 Feb; 44(2):139-150. PubMed ID: 28815663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiomics in gliomas: A promising assistance 
for glioma clinical research.
    Leng Y; Wang X; Liao W; Cao Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Apr; 43(4):354-359. PubMed ID: 29774870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 2021 WHO Classification for Gliomas and Implications on Imaging Diagnosis: Part 1-Key Points of the Fifth Edition and Summary of Imaging Findings on Adult-Type Diffuse Gliomas.
    Park YW; Vollmuth P; Foltyn-Dumitru M; Sahm F; Ahn SS; Chang JH; Kim SH
    J Magn Reson Imaging; 2023 Sep; 58(3):677-689. PubMed ID: 37069792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated molecular analysis suggests a three-class model for low-grade gliomas: a proof-of-concept study.
    Marko NF; Prayson RA; Barnett GH; Weil RJ
    Genomics; 2010 Jan; 95(1):16-24. PubMed ID: 19835948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multidimensional scaling of diffuse gliomas: application to the 2016 World Health Organization classification system with prognostically relevant molecular subtype discovery.
    Cimino PJ; Zager M; McFerrin L; Wirsching HG; Bolouri H; Hentschel B; von Deimling A; Jones D; Reifenberger G; Weller M; Holland EC
    Acta Neuropathol Commun; 2017 May; 5(1):39. PubMed ID: 28532485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.
    Louis DN; Perry A; Reifenberger G; von Deimling A; Figarella-Branger D; Cavenee WK; Ohgaki H; Wiestler OD; Kleihues P; Ellison DW
    Acta Neuropathol; 2016 Jun; 131(6):803-20. PubMed ID: 27157931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Revised WHO classification 2016 of gliomas : what's new ?].
    Brouland JP; Hottinger AF
    Rev Med Suisse; 2017 Oct; 13(579):1805-1809. PubMed ID: 29064198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pretreatment Evaluation of Glioma.
    Mohammadzadeh A; Mohammadzadeh V; Kooraki S; Sotoudeh H; Kadivar S; Shakiba M; Rasuli B; Borhani A; Mohammadzadeh M
    Neuroimaging Clin N Am; 2016 Nov; 26(4):567-580. PubMed ID: 27712794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Updated World Health Organization Glioma Classification: Cellular and Molecular Origins of Adult Infiltrating Gliomas.
    Pisapia DJ
    Arch Pathol Lab Med; 2017 Dec; 141(12):1633-1645. PubMed ID: 29189064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic, therapeutic, and prognostic implications of the 2021 World Health Organization classification of tumors of the central nervous system.
    Gritsch S; Batchelor TT; Gonzalez Castro LN
    Cancer; 2022 Jan; 128(1):47-58. PubMed ID: 34633681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.